There are 2789 resources available
504P - Prognostic factors of patients with AFP-positive colorectal cancer: A case-control study
Presenter: Min-Yi Lv
Session: ePoster Display
505TiP - REGINA: A phase II trial of neoadjuvant regorafenib (rego) in combination with nivolumab (nivo) and short-course radiotherapy (SCRT) in intermediate-risk, stage II-III rectal cancer (RC)
Presenter: Giacomo Bregni
Session: ePoster Display
506TiP - Pembrolizumab plus lenvatinib versus standard of care for previously treated metastatic colorectal cancer (mCRC): Phase III LEAP-017 study
Presenter: Takayuki Yoshino
Session: ePoster Display
558TiP - Phase I study of effector-function enhanced monoclonal antibody (mAb), SEA-TGT, in advanced malignancies
Presenter: Vincent Ribrag
Session: ePoster Display
559TiP - A phase II study of TAS-117 in patients with advanced solid tumors harboring germline PTEN inactivating mutations
Presenter: Jordi Rodon
Session: ePoster Display
560TiP - A phase I/IIa study to evaluate the safety and efficacy of CCS1477, a first in clinic inhibitor of p300/CBP, as monotherapy in patients with selected molecular alterations
Presenter: Simon Crabb
Session: ePoster Display
561TiP - A phase I dose-escalation study of ZN-d5, an BCL-2 inhibitor with improved selectivity, in patients with advanced non-Hodgkin lymphoma (NHL) or acute myeloid leukemia (AML)
Presenter: Jan Zaucha
Session: ePoster Display